Research from the labs of Francisco Sánchez-Rivera and Matthew Shoulders shows that tumors create an environment primed for certain dangerous mutations. The study draws on the Sanchez-Rivera group’s gene-editing tools and p53 expertise to show that elevated protein-folding networks buffer harmful TP53 variants, enabling tumor survival and growth, as well as drug resistance.